Sign Up to like & get
recommendations!
2
Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.683357
Abstract: Background: Direct oral factor Xa (FXa) inhibitors interfere with lupus anticoagulant (LA) assays challenging antiphospholipid syndrome diagnosis in treated patients. We evaluated a new device, called DOAC Filter, and its usefulness in this setting. It…
read more here.
Keywords:
fxa inhibitors;
rivaroxaban apixaban;
direct oral;
doac filter ... See more keywords